Analysts expect over 2018 rising revenue Novartis, high dividend yield

Novartis will announce it's last quarter's results tomorrow. Over the current book year the total revenue will be 52,17 billion CHF (consensus estimates). This is slightly more than 2017's revenue of 50,14 billion CHF.

Historical revenues and results Novartis plus estimates 2018

The analysts expect for 2018 a net profit of 12,08 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 5,18 CHF. The price/earnings-ratio is then 16,27.

Huge dividend Novartis

Analysts expect a dividend of 2,94 CHF per share. Novartis's dividend yield thus equals 3,49 percent. The average dividend yield of the pharmaceutical companies equals a low 0,5 percent.

Recent target prices around 87 CHF

UBS, JP Morgan and Morgan Stanley recently provided recommendations for the stock.

Novartis's market capitalization is around 200,13 billion CHF. The Novartis stock was the past 12 months quite unstable. Since last January the stock is 1 percent higher. This year the stock price moved between 72 and 93 CHF. Since 2008 the stock price is almost 78 percent higher.

On Monday the stock closed at 84,3 CHF.

Historical stock prices Novartis period 2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.